Lumexa Imaging Holdings, Inc. (LMRI) Financial Statements
Industry: Medical Laboratories (Services)
Open the full interactive Lumexa Imaging financials → Quarterly statements, key ratios, valuation history and price charts.
Lumexa Imaging Key Stats
| Share Price | $10.61 |
|---|---|
| 52-Week Range | $6.77 – $18.53 |
| Shares Outstanding | 96.0 million (basic, 2026 Q2) |
Lumexa Imaging Quarterly Results
| 2026 Q1 | 2026 Q2 | |
|---|---|---|
| Revenue | $252.5M | $264.2M |
| Net Income | $1.7M | $2.7M |
| Diluted EPS | $0.02 | $0.03 |
Figures from Lumexa Imaging's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Lumexa Imaging financials page for every line item.
Lumexa Imaging Company Profile
| Ticker | LMRI |
|---|---|
| Exchange | Nasdaq |
| Industry | Medical Laboratories (Services) |
| Headquarters | Raleigh, North Carolina |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, emerging growth company |
| SEC CIK | 0002071288 |